Metabolic Syndrome Market By Condition (Obesity, Hypertension, Insulin Resistance, Dyslipidemia, Prothrombotic and Proinflammatory States), By Diagnosis (Blood Glucose Testing, Lipid Profile Testing, Blood Pressure Monitoring, Waist Circumference Measurement, Others), By Treatment (Antihypertensive Drugs, Antidiabetic Drugs, Lipid-Lowering Agents, Anti-obesity Drugs, Lifestyle Modifications), By End-user (Hospitals, Clinics, Diagnostic Centers, Fitness & Wellness Centers, Homecare Settings, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Jun 2025 | Report ID: MI2978 | 218 Pages


Report Coverage:

By Condition

  • Obesity
  • Hypertension
  • Insulin Resistance
  • Dyslipidemia
  • Prothrombotic and Proinflammatory States

By Diagnosis

  • Blood Glucose Testing
  • Lipid Profile Testing
  • Blood Pressure Monitoring
  • Waist Circumference Measurement
  • Others

By Treatment

  • Antihypertensive Drugs
  • Antidiabetic Drugs
  • Lipid-Lowering Agents
  • Anti-Obesity Drugs
  • Lifestyle Modifications

By End-user

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Fitness & Wellness Centers
  • Homecare Settings
  • Others

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

List of Companies:

  • Novo Nordisk A/S
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi
  • AstraZeneca
  • Eli Lilly and Company
  • Novartis AG
  • GlaxoSmithKline plc
  • Bayer AG
  • Johnson & Johnson
  • Takeda Pharmaceutical Company Limited
  • Boehringer Ingelheim
  • Amgen Inc.
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.